Oral communications regression, three stable, three moderate), 16 PG (four regression, four stable, four moderate), 17 LAVVR (six regression, seven stable, four moderate). Image quality of micro-TEE was scored 1 for 2D and 2 for Doppler. In three patients on circulatory assistance, micro-TEE could be performed in PICU with good tolerance and acceptable quality.
regression, three stable, three moderate), 16 PG (four regression,Background.-Coronary compression (CC) may occur during percutaneous pulmonary valve implantation (PPVI) and is potentially life threatening when undiagnosed before right ventricular outflow tract (RVOT) stenting. We sought to evaluate its incidence, diagnosis and outcome. Methods.-All consecutive patients who underwent transcatheter RVOT treatment from May 2008 to December 2011 in two institutions were studied. Baseline demographics, diagnosis and outcomes of CC were reviewed with analysis of risk factors.
Results.-CC occurred in six out of 100 patients (6%) at a median age of 24 (13 to 49) years, with RVOT conduit stenosis as the primary lesion in all cases. The initial congenital heart disease was pulmonary atresia-ventricular septal defect (n = 3), complex transposition of the great arteries (n = 2) and critical aortic stenosis status-post Ross operation (n = 1). The RVOT initial median conduit diameter at surgical implantation was 23 (17 to 24) mm and conduit types were homograft (n = 3), bioprothesis (n = 2) and a pericardial patch (n = 1). CC was diagnosed by coronary angiogram during balloon dilation of the RVOT in all cases whereas it was suspected on pre-procedure computed tomography (CT-scan) in only two cases. Compression occurred on the left anterior descending coronary artery in four cases and on a right coronary artery that arose from the proximal left anterior descending coronary artery in two patients (single coronary artery). No risk factor was found but there was a significantly higher incidence of CC in one of the two institutions (P = 0.04). CC was well-tolerated and resolved after the balloon was deflated in all the cases. No patients underwent RVOT stenting or PPVI. Surgical conduit replacement was electively performed in three patients. Two patients with moderate residual RVOT stenosis are followed. One patient with encephalopathy and respiratory insufficiency died 9 months after catheterization. Methods.-We conducted a bicentric prospective study, of children, with patent ductus arteriosus, evaluating the evolution of systolic and diastolic ventricular function before, 1 day and 1 month after successful closure, by means of transthoracic echocardiography.
Conclusions
Results.-Thirty-three children, age 3 months to 14.5 years, underwent successful closure of their patent ductus arteriosus, 32 percutaneously and one surgically. All patent ductus arteriosus were closed for hemodynamic reasons, with a mean diameter of 3.6 ± 0.9 mm. There was a significant increase in systolic (100.6 ± 15.1 versus 95.4 ± 15.3 mmHg, P < 0.05) and diastolic (53.2 ± 17.1 versus 47.8 ± 17.2 mmHg, P < 0.05) blood pressures, immediately after the suppression of the shunt. Left ventricular fractional shortening and end-diastolic volumes index were significantly lower the day after closure (respectively 34.7 ± 5.5 versus 37.8 ± 4.7% and 47 ± 16.2 versus 54.6 ± 20.1 mL/m 2 ) and remained low compared to the preclosure state at follow-up (respectively 33.8 ± 5.4 versus 37.8 ± 4.7% and 47 ± 12.7 versus 54.6 ± 20.1 mL/m 2 ). A non-significant decrease in left ventricular filling pressures was observed. Right ventricular systolic parameters (TAPSE) were significantly lower 1 month after closure (19.3 ± 2.9 versus 21.4 ± 4.4 mm, P < 0.05). Objectives.-To describe the aims and rationale for planned delivery in a tertiary referral centre for foetuses with prenatal diagnosis of congenital heart disease. Methods and results.-Two thousand one hundred and thirty consecutive foetuses with congenital heart disease diagnosed from January 2002 to December 2011 were included: 1258 (59%) in-born neonates whose delivery was planned in our institution, 799 (38%) terminations of pregnancy, and 73 (3%) foetal deaths. For in-born, planned delivery was classified as 'certainly justified' for 899 (71%) for the following reasons: Rashkind atrioseptotomy in 344 cases, risk of aortic coarctation in 272 cases, ductal patency needed for pulmonary flow in 107 cases, ductal patency needed for systemic flow in 93 cases, need for an immediate intervention in 83 cases. For the remaining 359 in-born, planned delivery was classified as 'potentially justified' for the following reasons: possible need for ductal patency for pulmonary flow in 156 cases, for systemic flow in 35 cases (3%), incomplete congenital heart disease diagnosis in 94 cases, need to monitor neonatal tolerance of the defect in 51 cases. In these 359 in-born at risk, rationale for planned delivery was reviewed after birth. A posteriori, it was not necessary for 249 in-born (20%) in whom no intervention was needed during the first week, and confirmed to be necessary for 110 in-born (9%) -32 in whom diagnosis was different with a direct influence on management and with 78 who needed an intervention during the first week.
Conclusions.-Our study demonstrates that only one fifth of foetal congenital heart diseases delivered in a tertiary reference centre appears to be unnecessary. Conversely, one third of in-borns with only possible post-natal risk of cardiac complication were appropriately delivered in our institution, as they needed immediate specialized management. Heart transplantation in young children and infants may be controversial. The aim of this study was to review long-term follow-up of heart transplanted small children and assess prognosis and outcomes. Material and methods.-Patients who underwent orthotopic heart transplantation (OHT) within the first 3 years of life were included in the study. Demographics, clinical data, events, outcomes and survival were assessed. Results.-Among 96 paediatric heart transplantations performed in a French single-centre, 25 patients who underwent OHT at ≤ 3 years of age, were included in the study (10 males, 15 females). Among them, 10 (40%) were on VAD support at the time of OHT. Age at OHT was 1.5 ± 0.9 years (median 1.2). Underlying cardiac disease was congenital in four (16%) or idiopathic cardiomyopathy in 21 (84%). Post-transplant follow-up was 7.1 ± 7 years (range 1day to 22.7) and was > 10 years in seven cases (28%). Three patients died at first day, second year and fourth year post-transplant. Mean age of survivors at the time of the study was 9.1 ± 7.3 years (range 1.5 to 23.6). One acute rejection episode occurred at first month post-transplant and one at 11th year. One patient had posttransplant lympho-proliferative disease at 14th year post-transplant and was successfully cured. Graft coronary disease occurred in two cases (8%), who underwent second heart and kidney transplantation at 16th and 22nd year after first transplant. All other cases were free from coronary disease with normal graft function. End-stage renal failure occurred in the two re-transplanted cases. Significant severe renal dysfunction was present in three cases (no dialysis), moderate in three cases, and 17 had normal renal function. Linear growth ranged within normal in all patients, except the two cases with end-stage renal failure, despite continuous low dose steroid therapy in 80% of the survivors. All patients are in NYHA class I, except the two re-transplanted cases who were in NYHA class IV at the time of second transplant. Patient survival was 96% at 1-year, 90.7% at 3-year and 83% at 10-year post-transplant follow-up. Graft survival was respectively 96%, 90.7%, 83% and 66% at 1-, 3-, 10-and 16-year followup. Conclusion.-Long-term survival of very young heart transplant recipient is fairly good, with a low incidence of graft coronary disease and optimal functional status and growth. Results.-A VSD was present in 67% of all hearts and was: -constant, of a single type, in tetralogy of Fallot and variants and common arterial trunk: outlet, complete atrioventricular canal (CAVC): inlet, and double-inlet left ventricle (DILV): muscular; -not constant with a predominant type, in 96% of double discordance (inlet 82%), 62% of heterotaxy syndromes (Hetx, inlet 93%) 93% of interrupted aortic arch (outlet 80%), 87% of double outlet right ventricle (outlet 77%); -not constant, of variable type, in 68% of aortic coarctation (CoA: outlet 44%, membranous 35%, muscular 21%), 54% of transposition of the great arteries (TGA: outlet 40%, membranous 25%, muscular 25%, inlet 10%); -rare, in anomalies of pulmonary veins (5%), Ebstein anomaly (14%), double-inlet right ventricle (10%), coronary anomalies (25%); -isolated in 10% of all VSD: outlet 44%, membranous 36%, muscular 18%, inlet 2%. Associations were: -outlet VSD: 60% ''conotruncal'' defects (CTD), 10% TGA; -inlet: 57% CAVC, 13% DD, 10% Hetx; -muscular: 33% DILV, 26% TGA, 13% isolated; -membranous: 30% TGA, 28% isolated, 16% CoA. Conclusion.-The VSD is an integral part of the phenotype in some CHD (CTD, CAVC, and DILV). In CoA and TGA the VSD is not constant and its anatomic distribution is similar to that in isolated VSD, indicating a likely random association. This reinforces the hypothesis of different genetic mechanisms in TGA and CTD. This original approach, using the anatomic characteristics of one part of the phenotype, could provide new insights in the grouping and aetiology of CHD.
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